Bordeau BM[au] - Search Results

Year	Number of Results
2015	1
2016	1
2021	2
2022	5
2023	3

1

Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability.

Nguyen TD, Bordeau BM, Balthasar JP. Nguyen TD, et al. Among authors: bordeau bm. Cancers (Basel). 2023 Jan 24;15(3):713. doi: 10.3390/cancers15030713. Cancers (Basel). 2023. PMID: 36765668 Free PMC article. Review.

2

Strategies to enhance monoclonal antibody uptake and distribution in solid tumors.

Bordeau BM, Balthasar JP. Bordeau BM, et al. Cancer Biol Med. 2021 Aug 15;18(3):649-64. doi: 10.20892/j.issn.2095-3941.2020.0704. Cancer Biol Med. 2021. PMID: 35979855 Free PMC article. Review.

3

Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody-Drug Conjugates.

Bordeau BM, Nguyen TD, Polli JR, Chen P, Balthasar JP. Bordeau BM, et al. Mol Cancer Ther. 2023 Apr 3;22(4):459-470. doi: 10.1158/1535-7163.MCT-22-0440. Mol Cancer Ther. 2023. PMID: 36723609

4

Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy.

Polli JR, Chen P, Bordeau BM, Balthasar JP. Polli JR, et al. Among authors: bordeau bm. AAPS J. 2022 Mar 25;24(3):47. doi: 10.1208/s12248-022-00698-x. AAPS J. 2022. PMID: 35338415 Free PMC article.

5

Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Monoclonal Antibody Tumor Disposition.

Bordeau BM, Polli JR, Schweser F, Grimm HP, Richter WF, Balthasar JP. Bordeau BM, et al. Int J Mol Sci. 2022 Jan 8;23(2):679. doi: 10.3390/ijms23020679. Int J Mol Sci. 2022. PMID: 35054865 Free PMC article.

6

Development and Evaluation of Competitive Inhibitors of Trastuzumab-HER2 Binding to Bypass the Binding-Site Barrier.

Bordeau BM, Abuqayyas L, Nguyen TD, Chen P, Balthasar JP. Bordeau BM, et al. Front Pharmacol. 2022 Feb 18;13:837744. doi: 10.3389/fphar.2022.837744. eCollection 2022. Front Pharmacol. 2022. PMID: 35250584 Free PMC article.

7

Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid-Antibody-Drug Conjugates.

Nguyen TD, Bordeau BM, Balthasar JP. Nguyen TD, et al. Among authors: bordeau bm. Mol Cancer Ther. 2023 Jul 26:MCT-22-0804. doi: 10.1158/1535-7163.MCT-22-0804. Online ahead of print. Mol Cancer Ther. 2023. PMID: 37493255

8

Hedgehog Proteins Consume Steroidal CYP17A1 Antagonists: Potential Therapeutic Significance in Advanced Prostate Cancer.

Bordeau BM, Ciulla DA, Callahan BP. Bordeau BM, et al. ChemMedChem. 2016 Sep 20;11(18):1983-6. doi: 10.1002/cmdc.201600238. Epub 2016 Jul 20. ChemMedChem. 2016. PMID: 27435344 Free PMC article.

9

Förster resonance energy transfer-based cholesterolysis assay identifies a novel hedgehog inhibitor.

Owen TS, Ngoje G, Lageman TJ, Bordeau BM, Belfort M, Callahan BP. Owen TS, et al. Among authors: bordeau bm. Anal Biochem. 2015 Nov 1;488:1-5. doi: 10.1016/j.ab.2015.06.021. Epub 2015 Jun 18. Anal Biochem. 2015. PMID: 26095399 Free PMC article.

10

Transient Inhibition of Trastuzumab-Tumor Binding to Overcome the "Binding-Site Barrier" and Improve the Efficacy of a Trastuzumab-Gelonin Immunotoxin.

Chen P, Bordeau BM, Zhang Y, Balthasar JP. Chen P, et al. Among authors: bordeau bm. Mol Cancer Ther. 2022 Oct 7;21(10):1573-1582. doi: 10.1158/1535-7163.MCT-22-0192. Mol Cancer Ther. 2022. PMID: 35930739 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year